DR. HOWARD L MARTIN MD NPI 1366421927

NPI Information

  • NPI: 1366421927
  • Provider Name: DR. HOWARD L MARTIN, MD
  • Classification: Pathology - 207ZD0900X
  • Specialization: Dermatopathology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 4131 DIRECTORS ROW
    HOUSTON, TX
    ZIP 77092
  • Phone: (877) 697-2447

Map and Directions

Get Directions

NPI Details

DR. Howard L Martin, MD is a dermatopathology pathology in Houston, TX with 29 years of experience. The provider is a dermatopathologist is an expert in diagnosing and monitoring diseases of the skin including infectious, immunologic, degenerative, and neoplastic diseases. This entails the examination and interpretation of specially prepared tissue sections, cellular scrapings, and smears of skin lesions by means of light microscopy, electron microscopy, and fluorescence microscopy. DR. Howard L Martin, MD NPI is 1366421927. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL SCHOOL AT DALLAS
Graduation Year:1997

The provider's business location address is:

4131 DIRECTORS ROW
HOUSTON, TX
ZIP 77092-703
Phone: (877) 697-2447
Fax: (855) 697-2447

The NPI 1366421927 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Pathology examination of tissue using a microscope, intermediate complexity (HCPCS:88305)
  • Testing for presence of drug, by chemistry analyzers (HCPCS:80307)
  • Special stained specimen slides to examine tissue, each additional procedure (HCPCS:88341)
  • Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0483)
  • Special stained specimen slides to examine tissue, initial procedure (HCPCS:88342)
  • Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0480)
  • Special stained specimen slides to identify organisms including interpretation and report (HCPCS:88312)
  • Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0482)
  • Pathology examination of tissue using a microscope, moderately low complexity (HCPCS:88304)
  • Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0481)
  • Preparation of tissue for examination by removing any calcium present (HCPCS:88311)
  • Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
  • Antibody evaluation, each additional single antibody stain procedure (HCPCS:88350)
  • Special stained specimen slides to examine tissue including interpretation and report (HCPCS:88313)
  • Antibody evaluation, initial single antibody stain procedure (HCPCS:88346)
  • Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
  • Special stained specimen slides to examine tissue, each multiplex procedure (HCPCS:88344)
  • Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
  • Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique (HCPCS:87641)
  • Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique (HCPCS:87653)
  • Genetic sequencing localization, initial procedure (HCPCS:88365)
  • Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique (HCPCS:87651)
  • Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
  • Genetic sequencing localization, each additional procedure (HCPCS:88364)
  • Detection test by nucleic acid for human papillomavirus (hpv), high-risk types (HCPCS:87624)
  • Pathology examination of tissue using a microscope, moderately high complexity (HCPCS:88307)

The enumeration date for this NPI number is 1/12/2006 and was last updated on 7/22/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207ZD0900XPathologyDermatopathologyK6969TEXASYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.